The reliability of the sFlt-1/PlGF ratio in this regard is also shown by the fact that all four patients of the safety population who developed eclampsia, HELLP syndrome or both had been detected as having an increased risk by a markedly elevated sFlt-1/PlGF ratio before the clinical diagnosis of preeclampsia could be established. This evidence concerns the gene PGF and HELLP syndrome.